Superiority of conventional intensity-modulated radiotherapy over helical tomotherapy in locally advanced non-small cell lung cancer A comparative plan analysis

被引:7
|
作者
Song, C. [2 ,4 ]
Pyo, H. [1 ]
Kim, J. [1 ]
Lim, Y. K. [2 ]
Kim, W. C. [3 ]
Kim, H. J. [4 ]
Kim, D. W. [2 ]
Cho, K. H. [2 ]
机构
[1] Sungkyunkwan Univ, Dept Radiat Oncol, Samsung Med Ctr, Sch Med, Seoul 135710, South Korea
[2] Res Inst & Hosp, Proton Therapy Ctr, Natl Canc Ctr, Goyang, South Korea
[3] Inha Univ, Dept Radiat Oncol, Sch Med, Inchon, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea
关键词
Non-small cell lung cancer; Helical tomotherapy; Intensity-modulated radiotherapy; Radiation pneumonitis; Radiation dosage; CONFORMAL RADIOTHERAPY; RADIATION-THERAPY; DOSE-ESCALATION; IMRT TECHNIQUES; NORMAL TISSUE; PNEUMONITIS; IRRADIATION; TOXICITY; RISK; CHEMOTHERAPY;
D O I
10.1007/s00066-012-0159-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To compare helical tomotherapy (HT) and conventional intensity-modulated radiotherapy (IMRT) using a variety of dosimetric and radiobiologic indexes in patients with locally advanced non-small cell lung cancer (LA-NSCLC). A total of 20 patients with LA-NSCLC were enrolled. IMRT plans with 4-6 coplanar beams and HT plans were generated for each patient. Dose distributions and dosimetric indexes for the tumors and critical structures were computed for both plans and compared. Both modalities created highly conformal plans. They did not differ in the volumes of lung exposed to > 20 Gy of radiation. The average mean lung dose, volume receiving a parts per thousand yenaEuro parts per thousand 30 Gy, and volume receiving a parts per thousand yenaEuro parts per thousand 10 Gy in HT planning were 18.3 Gy, 18.5%, and 57.1%, respectively, compared to 19.4 Gy, 25.4%, and 48.9%, respectively, with IMRT (p = 0.004, p < 0.001, and p < 0.001). The differences between HT and IMRT in lung volume receiving a parts per thousand yenaEuro parts per thousand 10-20 Gy increased significantly as the planning target volume (PTV) increased. For 6 patients who had PTV greater than 700 cm(3), IMRT was superior to HT for 5 patients in terms of lung volume receiving a parts per thousand yenaEuro parts per thousand 5-20 Gy. The integral dose to the entire thorax in HT plans was significantly higher than in IMRT plans. HT gave significantly better control of mean lung dose and volume receiving a parts per thousand yenaEuro parts per thousand 30-40 Gy, whereas IMRT provided better control of the lung volume receiving a parts per thousand yenaEuro parts per thousand 5-15 Gy and the integral dose to entire thorax. In most patients with PTV greater than 700 cm(3), IMRT was superior to HT in terms of lung volume receiving a parts per thousand yenaEuro parts per thousand 5-20 Gy. It is therefore advised that caution should be exercised when planning LA-NSCLC using HT.
引用
收藏
页码:901 / 909
页数:9
相关论文
共 50 条
  • [31] Moderately escalated hypofractionated (chemo radiotherapy delivered with helical intensity-modulated technique in stage III unresectable non-small cell lung cancer
    Donato, Vittorio
    Arcangeli, Stefano
    Monaco, Alessia
    Caruso, Cristina
    Cianciulli, Michele
    Boboc, Genoveva
    Chiostrini, Cinzia
    Rauco, Roberta
    Pressello, Maria Cristina
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [32] An esophagus-sparing technique to limit radiation esophagitis in locally advanced non-small cell lung cancer treated by simultaneous integrated boost intensity-modulated radiotherapy and concurrent chemotherapy
    Ma, Li
    Qiu, Bo
    Li, Qiwen
    Chen, Li
    Wang, Bin
    Hu, YongHong
    Liu, MengZhong
    Zhang, Li
    Huang, Yan
    Deng, XiaoWu
    Xia, YunFei
    Lin, MaoSheng
    Liu, Hui
    RADIATION ONCOLOGY, 2018, 13
  • [33] Is clinical target volume necessary?-a failure pattern analysis in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy using intensity-modulated radiotherapy technique
    Zou, Liqing
    Chu, Li
    Xia, Fan
    Zhou, Lijun
    Yang, Xi
    Ni, Jianjiao
    Chen, Junchao
    Zhu, Zhengfei
    TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (05) : 1986 - +
  • [34] Combination of chemotherapy and radiotherapy for locally advanced non-small cell lung cancer
    Fournel, P.
    REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : S94 - S100
  • [35] Intensity-Modulated Radiotherapy in Treatment of Small Cell Lung Cancer
    Singh, Charu
    Gupta, Shivani
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S787 - S787
  • [36] Relationship between Treatment Plan Dosimetry, Toxicity, and Survival following Intensity-Modulated Radiotherapy, with or without Chemotherapy, for Stage III Inoperable Non-Small Cell Lung Cancer
    Remmerts de Vries, Isabel F.
    Ronden, Merle I.
    Bahce, Idris
    Spoelstra, Femke O. B.
    De Haan, Patricia F.
    Haasbeek, Cornelis J. A.
    Lissenberg-Witte, Birgit I.
    Slotman, Ben J.
    Dahele, Max
    Verbakel, Wilko F. A. R.
    CANCERS, 2021, 13 (23)
  • [37] Intensity-modulated radiotherapy, volume-modulated arc therapy and helical tomotherapy for locally advanced nasopharyngeal carcinoma: a dosimetric comparison
    Chen, Wen
    Yang, Xiaoyu
    Jiang, Nian
    Zhang, Zijian
    Hong, Jidong
    He, Yuxiang
    Luo, Junli
    Liang, Ying
    Wei, Rui
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (05) : 929 - 939
  • [38] Adaptive intensity-modulated radiotherapy with simultaneous integrated boost for stage III non-small cell lung cancer: Is a routine adaptation beneficial?
    Meng, Yinnan
    Luo, Wei
    Xu, Hailing
    Wang, Wei
    Zhou, Suna
    Tang, Xingni
    Li, Zihong
    Zhou, Chao
    Yang, Haihua
    RADIOTHERAPY AND ONCOLOGY, 2021, 158 : 118 - 124
  • [39] Comparison of photon intensity modulated, hybrid and volumetric modulated arc radiation treatment techniques in locally advanced non-small cell lung cancer
    Hattu, Djoya
    Emans, Daisy
    van der Stoep, Judith
    Canters, Richard
    van Loon, Judith
    De Ruysscher, Dirk
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2023, 28
  • [40] Comparison of proton therapy and intensity modulated photon radiotherapy for locally advanced non-small cell lung cancer: considerations for optimal trial design
    Cushman, Taylor R.
    Verma, Vivek
    Rwigema, Jean-Claude M.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S988 - S990